Baidu
map

国家医保局:新冠病毒抗原检测临时性纳入医保!

2022-03-23 国家医保局 网络

【国家医保局:新冠病毒抗原检测临时性纳入医保】

【国家医保局:#新冠病毒抗原检测临时性纳入医保#】为进一步加强新冠肺炎疫情防控医疗保障工作,国家医保局办公室21日印发《关于切实做好当前疫情防控医疗保障工作的通知》,明确参保人在定点基层医疗机构发生的相关费用按统筹地区现行规定支付,在定点零售药店购买新冠病毒抗原检测试剂的费用,可使用个人账户支付。

  通知明确,各省级医保部门要及时调整优化疫情防控医疗保障政策措施,按程序将新冠病毒抗原检测试剂及相应检测项目临时性纳入本省份基本医保医疗服务项目目录,持续规范和优化公立医疗机构提供新冠病毒抗原检测服务的价格政策。

  各省级医保部门要参照相关要求,将《新型冠状病毒肺炎诊疗方案(试行第九版)》新增药品临时性纳入本省份医保基金支付范围;对调出最新版诊疗方案且不在基本医保目录内的药品,应在最新版诊疗方案发布之日起停止医保支付。

  对新增的奈玛特韦片/利托那韦片,由医疗机构按照企业与有关部门沟通一致的价格采购,医保部门按规定做好支付。

  通知明确,支持疫情严重地区医疗机构正常运转,必要时可按程序预付部分新冠救治资金。同时,要扎实做好新冠病毒疫苗及接种费用保障,落实核酸和抗原检测项目价格政策,实施“长期处方”、互联网诊疗等结算报销政策。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1221962, encodeId=e1cf12219622d, content=<a href='/topic/show?id=e85c33804e5' target=_blank style='color:#2F92EE;'>#医保#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33804, encryptionId=e85c33804e5, topicName=医保)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=清风徐来2022, createdTime=Tue May 24 11:05:17 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280606, encodeId=fc00128060633, content=<a href='/topic/show?id=1bd3338451e' target=_blank style='color:#2F92EE;'>#医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33845, encryptionId=1bd3338451e, topicName=医保局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Fri Mar 25 05:55:25 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497312, encodeId=4c01149e31265, content=<a href='/topic/show?id=82b440848a4' target=_blank style='color:#2F92EE;'>#国家医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40848, encryptionId=82b440848a4, topicName=国家医保局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82569313637, createdName=雕雕, createdTime=Fri Mar 25 05:55:25 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623419, encodeId=ec8f16234190b, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55263, encryptionId=62a655263e9, topicName=抗原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f59b20519025, createdName=xiaoyeshuang, createdTime=Fri Mar 25 05:55:25 CST 2022, time=2022-03-25, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1221962, encodeId=e1cf12219622d, content=<a href='/topic/show?id=e85c33804e5' target=_blank style='color:#2F92EE;'>#医保#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33804, encryptionId=e85c33804e5, topicName=医保)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=清风徐来2022, createdTime=Tue May 24 11:05:17 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280606, encodeId=fc00128060633, content=<a href='/topic/show?id=1bd3338451e' target=_blank style='color:#2F92EE;'>#医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33845, encryptionId=1bd3338451e, topicName=医保局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Fri Mar 25 05:55:25 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497312, encodeId=4c01149e31265, content=<a href='/topic/show?id=82b440848a4' target=_blank style='color:#2F92EE;'>#国家医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40848, encryptionId=82b440848a4, topicName=国家医保局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82569313637, createdName=雕雕, createdTime=Fri Mar 25 05:55:25 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623419, encodeId=ec8f16234190b, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55263, encryptionId=62a655263e9, topicName=抗原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f59b20519025, createdName=xiaoyeshuang, createdTime=Fri Mar 25 05:55:25 CST 2022, time=2022-03-25, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1221962, encodeId=e1cf12219622d, content=<a href='/topic/show?id=e85c33804e5' target=_blank style='color:#2F92EE;'>#医保#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33804, encryptionId=e85c33804e5, topicName=医保)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=清风徐来2022, createdTime=Tue May 24 11:05:17 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280606, encodeId=fc00128060633, content=<a href='/topic/show?id=1bd3338451e' target=_blank style='color:#2F92EE;'>#医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33845, encryptionId=1bd3338451e, topicName=医保局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Fri Mar 25 05:55:25 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497312, encodeId=4c01149e31265, content=<a href='/topic/show?id=82b440848a4' target=_blank style='color:#2F92EE;'>#国家医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40848, encryptionId=82b440848a4, topicName=国家医保局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82569313637, createdName=雕雕, createdTime=Fri Mar 25 05:55:25 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623419, encodeId=ec8f16234190b, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55263, encryptionId=62a655263e9, topicName=抗原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f59b20519025, createdName=xiaoyeshuang, createdTime=Fri Mar 25 05:55:25 CST 2022, time=2022-03-25, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1221962, encodeId=e1cf12219622d, content=<a href='/topic/show?id=e85c33804e5' target=_blank style='color:#2F92EE;'>#医保#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33804, encryptionId=e85c33804e5, topicName=医保)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=清风徐来2022, createdTime=Tue May 24 11:05:17 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280606, encodeId=fc00128060633, content=<a href='/topic/show?id=1bd3338451e' target=_blank style='color:#2F92EE;'>#医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33845, encryptionId=1bd3338451e, topicName=医保局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Fri Mar 25 05:55:25 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497312, encodeId=4c01149e31265, content=<a href='/topic/show?id=82b440848a4' target=_blank style='color:#2F92EE;'>#国家医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40848, encryptionId=82b440848a4, topicName=国家医保局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82569313637, createdName=雕雕, createdTime=Fri Mar 25 05:55:25 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623419, encodeId=ec8f16234190b, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55263, encryptionId=62a655263e9, topicName=抗原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f59b20519025, createdName=xiaoyeshuang, createdTime=Fri Mar 25 05:55:25 CST 2022, time=2022-03-25, status=1, ipAttribution=)]

相关资讯

《柳叶刀》子刊:超过6%的欧洲人患有抑郁症

取公共卫生政策,例如提供充分的全民健康保险,可能会降低抑郁症的流行。

北京:医保个人账户可支付配偶、父母、子女相关医疗费用

北京市医疗保障局日前发布《关于城镇职工基本医疗保险个人账户使用范围的补充通知》,

诸任之:和医保局谈判的若干思路

近日,国家医疗保障局办公室关于印发按病种分值付费(DIP)医疗保障经办管理规程(试行)的通知。相信这是为提高各级医保管理能力做的样板。要真正落地,还需要各级医保管理部门出台可具体操作的细则。

海南7月1日起新增13种医疗机构制剂纳入医保支付范围,医疗机构制剂纳入医保成趋势

海南省医疗保障局印发《关于将新增部分符合评审条件的医疗机构制剂纳入海南省基本医疗保险支付范围及统一医保支付标准的通知》指出,自7月1日起,海南省将新增尿素乳膏、治胃丸等13种医疗机构制剂纳入基本医疗保

国家医保局发布,谈判药品配备第二批机构名单

6月18日,国家医保局发布谈判药品配备机构名单(第二批),本批次涉及92个药品,均为2020年谈判新增进入国家医保目录的品种。截至5月31日,92个药品在全国8.4万家定点医药机构配备,其中定点医疗机

有关“钱袋子”!医保迎来新调整~

多地发布消息,提升门诊待遇水平,将更多门诊费用纳入医保报销!

Baidu
map
Baidu
map
Baidu
map